<DOC>
	<DOCNO>NCT02902354</DOCNO>
	<brief_summary>To determine central blood pressure change normotensive woman receive nifedipine uterine contraction suppression</brief_summary>
	<brief_title>Changes Central Arterial Pressure Normotensive Women Taking Nifedipine Tocolysis</brief_title>
	<detailed_description>Only woman prescribe nifedipine tocolysis cover obstetrician approach participate study . The patient take nifedipine schedule , attain central arterial pressure read addition arterial waveform measurement . These collect : Before administration medication Every 20 minute 3 hour ( total 10 measurement ) -This time allow measurement approximately 2 half life Routine sphygmomanometry also complete test time All measurement collect study purpose , although nurse opportunity record routine blood pressure measurement charting/vital sign assessment desire . Once patient monitor 3 hour , participation study consider complete additional information collect . Each patient serve control ( blood pressure prior administration medication ) , randomization occur .</detailed_description>
	<mesh_term>Nifedipine</mesh_term>
	<criteria>Singleton pregnancy Currently receive tocolysis nifedipine ( 10 20mg q46 hour ) Multiple pregnancy Diagnosis hypertensive disorder pregnancy blood pressure 140/90 high 2 occasion . Currently antihypertensive medication ( Nifedipine XL , labetalol , hydralazine , methyldopa , etc ) Currently tocolytic medication ( exp : magnesium , Indocin ) Narcotic use Renal diseaseI Irregular heart rhythm arrhythmias Peripheral arterial disease , leg artery disease Reynaud 's phenomenon Intense cold/hypothermia If wound location central arterial cuff would place tonometer carotid assessment Severe tachycardia ( &gt; 120 ) Greater 1st degree heart block Severe asthma Congestive heart failure heart disease Lupus , rheumatoid arthritis Inability adequately monitor BP Magnesium treatment</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>